Following the initial in vivo study on bacterial sepsis, clinical investigations of the Bioelectrical Epigenetic Programming method—modeled for the purpose of acquiring real-world data—were planned to encompass all primary viral pathogen groups, including enveloped/non-enveloped and DNA/RNA genomic structures, in order to observe the scope of viral impact across all structural variations.
|
Virus Species (Family)
|
Genome Configuration
|
Envelope Status
|
|
SARS-CoV-2 (Coronaviridae)
|
ssRNA (+)
|
Enveloped
|
|
Parvovirus (Parvoviridae)
|
ssDNA
|
Non-enveloped
|
|
FCoV (Coronaviridae)
|
ssRNA (+)
|
Enveloped
|
To evaluate the therapeutic activity on viral clearance and the pathophysiological processes triggered by these variations, prospective clinical investigations examining four distinct pathophysiological effects across three different mammalian species were designed. These studies were conducted and reported by independent investigators within the framework of standards and regulatory requirements.
Pathological Mechanisms and Clinical Indicators
|
Fundamental Pathophysiological Mechanism
|
Characteristic Clinical Indicators
|
|
Breach of the blood-brain barrier by infected macrophages; necrotizing vasculitis and pyogranulomatous inflammation in the vessel walls of the meninges, choroid plexus, and neural parenchyma.
|
Progressive neurological deficits and autonomic dysfunction secondary to brainstem involvement.
|
|
Widespread fibrino-necrotizing vasculitis due to viral antigen-antibody immune complex deposition, and pyogranulomatous inflammation on serosal surfaces.
|
Proteinaceous effusion accumulation in body cavities due to increased vascular permeability, and progressive multiorgan dysfunction.
|
|
Tropism for rapidly dividing cells; necrosis in intestinal crypts and villous atrophy; profound leukopenia/immunosuppression secondary to lymphoid tissue and bone marrow damage.
|
Severe hemorrhagic enteritis, SIRS secondary to bacterial translocation, sepsis, and progressive multiorgan dysfunction.
|
|
Diffuse alveolar damage (DAD) and severe inflammatory response (endothelialitis) in the vascular endothelium and lung parenchyma mediated via ACE2 receptors.
|
Progressive multiorgan dysfunction characterized by systemic coagulopathy, cytokine storm, and alveolo-capillary membrane destruction.
|
Findings
Data obtained from the independent preclinical and clinical investigations indicate that the method demonstrates a consistent 'pathogen-agnostic' efficacy profile across viral agents with diverse structural (enveloped/non-enveloped) and genomic (RNA/DNA) characteristics, as well as bacteria of distinct biological structures. In light of the data derived from clinical models, the effects of the method on the following biological processes were observed:
-
Circulatory System: Restoration of endothelial barrier integrity and modulation of vasculitis-induced necrotic processes.
-
Immune System: Repair of lymphoid tissue and bone marrow damage, alongside regulation and alignment of the immune response toward homeostatic levels.
-
Neurological System: Re-establishment of blood-brain barrier (BBB) integrity and suppression of necrotizing vasculitis and pyogranulomatous inflammation processes.
-
Digestive System: Stabilization of hemorrhagic enteritis and associated systemic inflammatory response syndrome (SIRS) processes through the structural repair of the epithelial barrier."
Disclaimer: The findings presented in this section are based on clinical investigations conducted by independent investigators in compliance with regulatory requirements. This information is intended solely to provide insights into the ongoing scientific and clinical research processes of the Bioelectrical Epigenetic Programming method and does not constitute a direct therapeutic recommendation or a commercial claim. The regulatory clearance processes for the method are ongoing. Methodological details, multiple datasets, and biostatistical analyses are currently under editorial preparation for publication in peer-reviewed journals.